StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report sent to ...
Capricor Therapeutics (CAPR) announced long-term data from its ongoing HOPE-2 open label extension clinical trial, demonstrating the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback